Prediabetes
Stories
-
Dexa Medica Group registers completed Phase 3 trial of DLBS3233 in prediabetes
The study enrolled 120 participants and was first posted on ClinicalTrials.gov on November 16, 2026. It compared DLBS3233 at 100 mg and 200 mg once daily to Metformin XR 500 mg twice daily over a 12-week course of therapy.